GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for 3-methyl-2-oxobutanoate hydroxymethyltransferase (B0VKK4)

Analyse AlphaFold monomer V2.0 prediction for 3-methyl-2-oxobutanoate… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B0VKK4
Type
protein
Length
269 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x4e5aaf9B2C8fC6fFcAb33fce8bed6cF7e1e258D2
Molecule
3-methyl-2-oxobutanoate hydroxymethyltransferase
UniProt
B0VKK4
Pockets
2 · best druggability 0.68

Structure

1 distinct chain · 43% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3-methyl-2-oxobutanoate hydroxymethyltransferaseprotein26943% helix, 14% strandB0VKK4

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12860.680.8335empty
2940.390.7621empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.